The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index; 9 of the 46 sources its claims cite were checked for support.
European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants
Open accessAbstract
Objectives: Thyroid biomarkers are fundamental for the diagnosis of thyroid disorders and for the monitoring and treatment of patients with these diseases. The knowledge of biological variation (BV) is important to define analytical performance specifications (APS) and reference change values (RCV). The aim of this study was to deliver BV estimates for thyroid stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3), thyroglobulin (TG), and calcitonin (CT). Methods: Analyses were performed on serum samples obtained from the European Biological Variation Study population (91 healthy individuals from six European laboratories; 21–69 years) on the Roche Cobas e801 at the San Raffaele Hospital (Milan, Italy). All samples from each individual were evaluated in duplicate within a single run. The BV estimates with 95% CIs were obtained by CV-ANOVA, after analysis of variance homogeneity and outliers. Results: The within-subject (CV I ) BV estimates were for TSH 17.7%, FT3 5.0%, FT4 4.8%, TG 10.3, and CT 13.0%, all significantly lower than those reported in the literature. No significant differences were observed for BV estimates between men and women. Conclusions: The availability of updated, in the case of CT not previously published, BV estimates for thyroid markers based on the large scale EuBIVAS study allows for refined APS and associated RCV applicable in the diagnosis and management of thyroid and related diseases.
Overview
CoChat Summary
TL;DR
This EuBIVAS analysis estimated biological variation for five serum thyroid markers in 91 healthy adults sampled weekly across six European laboratories. It reports lower within-subject variation than most prior literature for TSH, FT3, FT4, and TG, and provides previously unavailable estimates for calcitonin.
Key findings
- Within-subject biological variation (CV I) was 17.7% for TSH, 5.0% for FT3, 4.8% for FT4, 10.3% for TG, and 13.0% for CT; the authors state these were significantly lower than literature values for the markers with prior data.
- CV I estimates did not differ significantly between men and women, but mean concentrations differed by sex for TSH, FT3, FT4, and CT; TSH was higher in women, while FT3, FT4, and CT were higher in men.
- Derived reference change values for a 95% probability of significant unidirectional change were 50.7% for TSH, 12.6% for FT4, 13.1% for FT3, 29.0% for TG, and 36.4% for CT.
- The number of samples needed to approximate the homeostatic set point at 10% deviation was 13 for TSH, 5 for TG, and 8 for CT; at 15% deviation it was 6 for TSH, 3 for TG, and 4 for CT, while FT4 and FT3 required only one sample at 15%.
Methods
- The study used the EuBIVAS cohort: 91 healthy participants aged 21–69 years from six laboratories in five European countries, including 53 women and 38 men, with weekly blood collections over 10 weeks.
- Serum samples were analyzed in duplicate within a single run on a Roche Cobas e801 using ECLIA at San Raffaele Hospital, Milan.
- Biological variation components and 95% CIs were estimated by CV-ANOVA after outlier and homogeneity checks; APS, RCV, and NHSP were calculated from the resulting CV I, CV G, and CV A estimates.
Limitations
- The authors note that analyses used only one manufacturer’s reagents, samples were stored at −80 °C and thawed before analysis, and collection was standardized to 08:00–10:00, which matters given diurnal variation, especially for TSH.
- The authors caution that estimates come from healthy adults and weekly sampling, so applying RCVs to diseased populations or to less frequent clinical sampling requires caution, particularly for seasonally influenced markers such as TSH.
- The text also makes evident that many results were excluded to achieve homogeneity, including 22 subjects below the limit of quantitation for CT and one for TG, and that TSH between-country differences may limit applicability of TSH CV G and bias APS to all populations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
5 Valid · 0 Not valid · 27 Not checked · 55 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This includes a high number of smokers and the highest mean BMI in the Turkish cohort [18], which may explain the higher TSH results that were found in this group.”
§ European Biological Variation Study (EuBIVAS): within-and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants > Discussion
What the sources say
- Partly supportedcites [18] Bottani, M, Banfi, G, Guerra, E, Locatelli, M, Aarsand, AK, Coşkun, A, et al.. European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum biointact parathyroid hormone based on weekly samplings from 91 healthy participants. Ann Transl Med 2020;8:855. https://doi.org/10.21037/atm-19-4498. sourceExperimental — accuracy not yet measured
Supplementary Table S2 (Additional information; page not specified) records seven smokers among the 15 Turkish participants, supporting the smoking description. Table S1 shows the highest median BMI for Turkish men, but reports neither a mean BMI nor the highest BMI for the Turkish cohort as a whole. The paper studies PTH, not TSH; the proposed TSH explanation is the citing authors’ inference. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Considering the diurnal variation of especially TSH [22]”
§ European Biological Variation Study (EuBIVAS): within-and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants > Study limitations
What the sources say
- Supportedcites [22] Razvi, S, Bhana, S, Mrabeti, S. Challenges in interpreting thyroid stimulating hormone results in the diagnosis of thyroid dysfunction. J Thyroid Res 2019;2019:4106816. https://doi.org/10.1155/2019/4106816. source
Section 3.2.6 'Diurnal and Circannual Variations in TSH Levels' (p. ~5) states directly that 'A diurnal variation exists for TSH levels in euthyroid and hypothyroid patients (treated or untreated), with lower values in the daytime', with the nadir around midday. The same section also notes a circannual variation, reinforcing that TSH is the marker with day-to-day/within-day biological variation discussed in this paper. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, for TG three subjects were identified as outliers (two men and one woman) by the Dixon-q test, and thus not included in the CV G estimate.”
§ European Biological Variation Study (EuBIVAS): within-and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants > Results
plainn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For all the measurands, the mean concentration of all samples did not change during the 10 weeks of the study (data not shown).”
§ European Biological Variation Study (EuBIVAS): within-and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The within-subject (CV I ) BV estimates were for TSH 17.7%, FT3 5.0%, FT4 4.8%, TG 10.3, and CT 13.0%, all significantly lower than those reported in the literature.”
§ European Biological Variation Study (EuBIVAS): within-and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants > Abstract
plainn = 91- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
33 more claims
Create a free account to see all 87 claims and to verify the 37 references still open.
- Probably not a substantial claim. 30
- It may state two separate claims as one. 32
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The second finding from EuBIVAS is that, for some measurands, significant differences between mean BV estimates were found in subgroups e.g., males/females; menopausal/fertile women; or for other occasional subgroups (e.g. for creatinine [24] and thyroid hormones [35], for which the country of origin was considered).”
From The European Biological Variation Study (EuBIVAS): a summary report (2022) · cites this paper as [35]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the literature, while the CVI value of TSH was higher than in the study of Bottani et al. and lower than in the study of Maes et al., the CVG values for all tests in our study were not found to be different from other studies (6, 7).”
From Biological variation of thyroid stimulating hormone, free triiodothyronine and free thyroxine in healthy subjects in Turkey (2025) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“probably due to lifestyle differences and/or other factors linked to the ethnicity [35].”
From The European Biological Variation Study (EuBIVAS): a summary report (2022) · cites this paper as [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the literature, while the CVI value of TSH was higher than in the study of Bottani et al. and lower than in the study of Maes et al., the CVG values for all tests in our study were not found to be different from other studies (6, 7).”
From Biological variation of thyroid stimulating hormone, free triiodothyronine and free thyroxine in healthy subjects in Turkey (2025) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“In this study, the CVI and CVG estimates for TSH, FT3, and FT4 in patients with T2DM are similar to those reported in the European Biological Variation Study, which is also a mid-term study (30).”
From Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus (2025) · cites this paper as [30]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ European Biological Variation Study (EuBIVAS): within-and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants > Abstract
“all significantly lower than those reported in the literature.”
§ European Biological Variation Study (EuBIVAS): within-and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants > Discussion
“even if for the latter, 12.8%, is not significantly different based on evaluation of the 95% CI; 10.0-17.1 [35].”
Citations
Cites
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Lazarus, J., Brown, R. S., Daumerie, C., Hubalewska-Dydejczyk, A., Negro, R., & Vaidya, B. (2014) · European Thyroid Journal · doi:10.1159/000362597 · Cited by 742
Sandberg, S., Fraser, C. G., Horvath, A. R., Jansen, R., Jones, G., Oosterhuis, W., Petersen, P. H., Schimmel, H., Sikaris, K., & Panteghini, M. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0067 · Cited by 563
Self-citationThe Evidence for a Narrower Thyrotropin Reference Range Is Compelling
Wartofsky, L., & Dickey, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0455 · Cited by 424
Biondi, B., Bartalena, L., Cooper, D. S., Hegedüs, L., Laurberg, P., & Kahaly, G. J. (2015) · European Thyroid Journal · doi:10.1159/000438750 · Cited by 323
Fraser, C. G. (2012) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2011.733 · Cited by 286
Cited by
Van Uytfanghe, K., Ehrenkranz, J., Halsall, D., Hoff, K., Loh, T. P., Spencer, C. A., Köhrle, J., & ATA Thyroid Function Tests Writing Group (2023) · Thyroid® · doi:10.1089/thy.2023.0169 · Cited by 100
The European Biological Variation Study (EuBIVAS): a summary report
Carobene, A., Aarsand, A. K., Bartlett, W. A., Coskun, A., Diaz-Garzon, J., Fernandez-Calle, P., Guerra, E., Jonker, N., Locatelli, M., Plebani, M., et al. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0370 · Cited by 84
Self-citationBiological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals
Brum, W. S., Ashton, N. J., Simrén, J., Molfetta, G. D., Karikari, T. K., Benedet, A. L., Zimmer, E. R., Lantero‐Rodriguez, J., Montoliu‐Gaya, L., Jeromin, A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13518 · Cited by 79
Self-citationFernández-Calle, P., Díaz-Garzón, J., Bartlett, W., Sandberg, S., Braga, F., Beatriz, B., Carobene, A., Coskun, A., Gonzalez-Lao, E., Marques, F., et al. (2022) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0904 · Cited by 31
Self-citationCoşkun, A., Ertaylan, G., Pusparum, M., Hoof, R. V., Kaya, Z. Z., Khosravi, A., & Zarrabi, A. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167339 · Cited by 31
Self-citation
Metadata
- Authors
- Bottani, M., Aarsand, A. K., Banfi, G., Locatelli, M., Coşkun, A., Díaz-Garzón, J., Fernandez-Calle, P., Sandberg, S., Ceriotti, F., & Carobene, A.
- Affiliations
- IRCCS Ospedale Galeazzi - Sant'Ambrogio (IT)
- Haukeland University Hospital (NO)
- Vita-Salute San Raffaele University (IT)
- IRCCS Ospedale San Raffaele (IT)
- Acıbadem University (TR)
- Hospital Universitario La Paz , Madrid , Spain
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Corresponding author
- Carobene, Anna
- ORCID
- Venue
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Publisher
- Walter de Gruyter GmbH
- Published
- 2021-02-09
- Volume
- 60
- Issue
- 4
- Pages
- 523-532
- ISSN
- 1434-6621 (ISSN-L)
- 1437-4331
- OpenAlex
- W3126449714
- Semantic Scholar
- b7bf1c78c7d32b533217030a50ffe400a9bdb55d
- Cited by
- 46
- References
- 41
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 9 · 2023: 11 · 2022: 6 · 2021: 3
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Chemistry and Laboratory Medicine (CCLM) (publishedVersion)
- PubMed (publishedVersion)
- Acibadem University Open Access Repository (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Reliability and Agreement in Measurement
- Keywords
- biological variation, thyroid-stimulating hormone, free thyroxine, free triiodothyronine, thyroglobulin, calcitonin, reference change value, analytical performance specifications, healthy volunteers, sex differences
- MeSH terms
- Biological Variation, Population, Female, Humans, Male, Reference Values, Thyroid Gland, Thyrotropin, Thyroxine, Triiodothyronine, Biomarkers, Healthy Volunteers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants. https://app.cochat.ai/papers/10.1515/cclm-2020-1885
- The paper
- Bottani, M., Aarsand, A. K., Banfi, G., Locatelli, M., Coşkun, A., Díaz-Garzón, J., Fernandez-Calle, P., Sandberg, S., Ceriotti, F., & Carobene, A. (2022). European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2020-1885
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.